Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-07-001208
Filing Date
2007-03-29
Accepted
2007-03-29 13:47:27
Documents
1
Period of Report
2007-03-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 44046
  Complete submission text file 0001127602-07-001208.txt   46102
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Issuer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1605 CURTIS BRIDGE ROAD WILKESBORO NC 28697
Business Address 1605 CURTIS BRIDGE ROAD WILKERSON NC 28697 3366585377
INGRAM ROBERT ALEXANDER (Reporting) CIK: 0001219890 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15190 | Film No.: 07726942